{
   "debug": {
     "rawResponse": "Valid NEST response built from a successful low level call on POST: /bnf/document/_search?typed_keys=true\r\n# Audit trail of this API call:\r\n - [1] HealthyResponse: Node: http://beta-elastic-6-cluster.nice.org.uk:9200/ Took: 00:00:00.0128962\r\n# Request:\r\n{\"from\":0,\"size\":10,\"highlight\":{\"pre_tags\":[\"<mark>\"],\"post_tags\":[\"</mark>\"],\"fields\":{\"content\":{\"fragment_size\":150,\"no_match_size\":150,\"type\":\"fvh\",\"matched_fields\":[\"content\",\"content.plain\"]},\"title\":{\"pre_tags\":[\"<b>\"],\"post_tags\":[\"</b>\"],\"fragment_size\":300,\"number_of_fragments\":0,\"type\":\"fvh\",\"matched_fields\":[\"title\",\"title.plain\"]}}},\"_source\":{\"excludes\":[\"content\"]},\"aggs\":{\"unique_count\":{\"cardinality\":{\"field\":\"clusterid\"}}},\"query\":{\"function_score\":{\"query\":{\"function_score\":{\"query\":{\"bool\":{\"should\":[{\"bool\":{\"should\":[{\"bool\":{\"must\":[{\"query_string\":{\"type\":\"best_fields\",\"query\":\"CANCER\",\"default_operator\":\"and\",\"analyzer\":\"fulltext_query\",\"analyze_wildcard\":true,\"fields\":[\"content\",\"title^2\",\"primarydrug\",\"metadescription\",\"headings\",\"keywords\"],\"tie_breaker\":1.0,\"quote_field_suffix\":\".plain\",\"auto_generate_synonyms_phrase_query\":false}}]}},{\"bool\":{\"must\":[{\"query_string\":{\"type\":\"best_fields\",\"query\":\"CANCER\",\"default_operator\":\"and\",\"analyzer\":\"fulltext_no_synonyms\",\"analyze_wildcard\":true,\"fields\":[\"content.plain\",\"title.plain^2\",\"metadescription.plain\",\"keywords.plain\"],\"tie_breaker\":1.0,\"quote_field_suffix\":\".plain\",\"auto_generate_synonyms_phrase_query\":false}}]}},{\"bool\":{\"must\":[{\"multi_match\":{\"type\":\"phrase\",\"query\":\"CANCER\",\"analyzer\":\"standard\",\"fields\":[\"title.plain\",\"content.plain\",\"metadescription.plain\"]}}]}}]}}]}},\"functions\":[{\"field_value_factor\":{\"field\":\"boostvalue\",\"factor\":0.01}}],\"score_mode\":\"multiply\"}},\"functions\":[{\"weight\":1.0}],\"score_mode\":\"multiply\"}}}\r\n# Response:\r\n{\"took\":6,\"timed_out\":false,\"_shards\":{\"total\":1,\"successful\":1,\"skipped\":0,\"failed\":0},\"hits\":{\"total\":555,\"max_score\":92.83423,\"hits\":[{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2526117\",\"_score\":92.83423,\"_source\":{\"altsourceshort\":[\"BNFTS\"],\"autocomplete\":\"Breast cancer\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/\",\"accredited\":\"False\",\"clusterid\":-2526117,\"title\":\"Breast cancer | Treatment summary\",\"url\":\"https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/\",\"landing_url\":\"https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/\",\"topicType\":\"Treatment summary\",\"typeAheadLink\":\"/treatment-summaries/breast-cancer/\",\"boostvalue\":150,\"feedertype\":\"pfeeders\",\"typeAheadType\":\"TreatmentSummary\",\"source_name\":\"BNF Treatment Summaries BNF\"},\"highlight\":{\"title\":[\"Breast <b>cancer</b> | Treatment summary\"],\"content\":[\"Description of condition  Breast <mark>cancer</mark> is the most common form of malignancy in women, especially in those aged over 50 years. Established risk factors\",\"breast <mark>cancer.</mark> The use of oral contraceptives or hormone replacement therapy (HRT) is also associated with an increased risk of breast <mark>cancer.</mark> Breast cancer\",\"<mark>cancer</mark> in men is rare. Although risk factors are not fully understood, it may be associated with abnormalities of sex hormone metabolism, including those\",\"breast-feeding protect against breast <mark>cancer.</mark> Non-invasive breast <mark>cancer</mark>, also known as ductal carcinoma in situ , is when the <mark>cancer</mark> remains localised in the ducts\",\"ducts. However, in most cases, the <mark>cancer</mark> is invasive at the time of diagnosis, which means that malignant cells are liable to spread beyond the immediate\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2526287\",\"_score\":92.2832,\"_source\":{\"altsourceshort\":[\"BNFTS\"],\"autocomplete\":\"Prostate cancer\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/\",\"accredited\":\"False\",\"clusterid\":-2526287,\"title\":\"Prostate cancer | Treatment summary\",\"url\":\"https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/\",\"landing_url\":\"https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/\",\"topicType\":\"Treatment summary\",\"typeAheadLink\":\"/treatment-summaries/prostate-cancer/\",\"boostvalue\":150,\"feedertype\":\"pfeeders\",\"typeAheadType\":\"TreatmentSummary\",\"source_name\":\"BNF Treatment Summaries BNF\"},\"highlight\":{\"title\":[\"Prostate <b>cancer</b> | Treatment summary\"],\"content\":[\"Description of condition Prostate <mark>cancer</mark> is the most common form of <mark>cancer</mark> affecting men. It can also affect transgender women, as the prostate is usually\",\"black African-Caribbean men), obesity, and a familial component. Prostate <mark>cancer</mark> is usually slow-growing and asymptomatic at diagnosis, however, the presenting\",\"Hormone therapy and chemotherapy aim to slow the progression of prostate <mark>cancer</mark> and to control symptoms. In metastatic disease, treatment is aimed at prolonging\",\"     Overview     \\n        Treatment options for patients with prostate <mark>cancer</mark> include watchful waiting, active surveillance, prostatectomy, radiotherapy\",\"Watchful waiting is a strategy for 'controlling' rather than 'curing' prostate <mark>cancer</mark> and is aimed at patients in whom curative treatment is unsuitable or declined\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2521800\",\"_score\":44.855076,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2521800,\"title\":\"Pembrolizumab | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"lung <mark>cancer</mark>,   Urothelial carcinoma,  Classical Hodgkin lymphoma,  Head and neck squamous cell carcinoma,  Renal cell carcinoma,  Colorectal <mark>cancer</mark>,  Oesophageal\",\"Oesophageal carcinoma,  Breast <mark>cancer</mark>,  Endometrial carcinoma,  Cervical <mark>cancer</mark>,  Gastric <mark>cancer</mark>,  Small intestine <mark>cancer</mark>,  Biliary <mark>cancer</mark>  for pembrolizumab  By\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2512665\",\"_score\":44.110954,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2512665,\"title\":\"Bevacizumab | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"Colorectal <mark>cancer</mark> (specialist use only),  Breast <mark>cancer</mark> (specialist use only),  Renal cell carcinoma (specialist use only),  Non-small cell lung <mark>cancer</mark> (specialist\",\"only),  Epithelial ovarian <mark>cancer</mark> (specialist use only),  Fallopian tube <mark>cancer</mark> (specialist use only),  Primary peritoneal <mark>cancer</mark> (specialist use only), \"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2516148\",\"_score\":44.09298,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2516148,\"title\":\"Epirubicin hydrochloride | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"hydrochloride Breast <mark>cancer</mark> (specialist use only),  Gastric <mark>cancer</mark> (specialist use only),  Small cell lung <mark>cancer</mark> (specialist use only),  Ovarian <mark>cancer</mark> (specialist\",\"(specialist use only),  Colorectal <mark>cancer</mark> (specialist use only),  Lymphoma (specialist use only),  Leukaemia (specialist use only),  Multiple myeloma (specialist\",\"infusion Adult (consult product literature or local protocols).     Bladder <mark>cancer</mark> (specialist use only)  for epirubicin hydrochloride  By intravesical instillation\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2515538\",\"_score\":43.48902,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2515538,\"title\":\"Docetaxel | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"node-negative breast <mark>cancer</mark> (in combination with doxorubicin and cyclophosphamide),  Initial chemotherapy of locally advanced or metastatic breast <mark>cancer</mark> (with doxorubicin)\",\"doxorubicin),  Locally advanced or metastatic breast <mark>cancer</mark> where cytotoxic chemotherapy with an anthracycline or an alkylating drug has failed (monotherapy)\",\"breast <mark>cancer</mark> where cytotoxic chemotherapy with an anthracycline has failed (with capecitabine),  Initial chemotherapy of metastatic breast <mark>cancer</mark> which\",\"lung <mark>cancer</mark> where previous chemotherapy has failed,  Initial chemotherapy of unresectable, locally advanced or metastatic non-small cell lung <mark>cancer</mark> (with\",\"(with cisplatin),  Hormone-resistant metastatic prostate <mark>cancer</mark> (in combination with prednisone or prednisolone),  Initial treatment of metastatic gastric\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2525112\",\"_score\":43.454853,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2525112,\"title\":\"Trastuzumab | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"breast <mark>cancer</mark> which overexpresses human epidermal growth factor receptor-2 (HER2) (initiated by a specialist),  Treatment of metastatic breast <mark>cancer</mark> in patients\",\"HER2-positive tumours who have not received chemotherapy for metastatic breast <mark>cancer</mark> and in whom anthracycline treatment is inappropriate (in combination with\",\"docetaxel) (initiated by a specialist),  Treatment of metastatic breast <mark>cancer</mark> in postmenopausal patients with hormone-receptor positive HER2-positive\",\"product literature or local protocols).     Monotherapy for metastatic breast <mark>cancer</mark> in patients with tumours that overexpress HER2 who have received at least\",\"breast <mark>cancer</mark> should also have received hormonal therapy (consult product literature or local protocols).     Treatment of metastatic gastric <mark>cancer</mark> in patients\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2520919\",\"_score\":43.159054,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2520919,\"title\":\"Niraparib | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"Advanced ovarian <mark>cancer</mark> (initiated by a specialist),  Advanced fallopian tube <mark>cancer</mark> (initiated by a specialist),  Advanced peritoneal <mark>cancer</mark> (initiated by\",\"Relapsed ovarian <mark>cancer</mark> (initiated by a specialist),  Relapsed fallopian tube <mark>cancer</mark> (initiated by a specialist),  Relapsed peritoneal <mark>cancer</mark> (initiated by\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2517710\",\"_score\":43.084724,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2517710,\"title\":\"Goserelin | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"Indications and dose   Show For Zoladex LA ®  Locally advanced prostate <mark>cancer</mark> as an alternative to surgical castration,  Adjuvant treatment to radiotherapy\",\"advanced prostate <mark>cancer</mark>,  Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate <mark>cancer</mark>,  Metastatic\",\"Metastatic prostate <mark>cancer</mark>  for Zoladex LA ®  By subcutaneous injection Adult 10.8 mg every 12 weeks, to be administered into the anterior abdominal wall.      \",\"   Show For Zoladex ®  Locally advanced prostate <mark>cancer</mark> as an alternative to surgical castration,  Adjuvant treatment to radiotherapy or radical prostatectomy\",\"advanced prostate <mark>cancer</mark>,  Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate <mark>cancer</mark>,  Metastatic\"]}},{\"_index\":\"bnf_2022_06_22\",\"_type\":\"document\",\"_id\":\"2521517\",\"_score\":43.07801,\"_source\":{\"altsourceshort\":[\"BNFBNF\"],\"refresh\":\"1602\",\"destinationurl\":\"https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose\",\"accredited\":\"False\",\"clusterid\":-2521517,\"title\":\"Paclitaxel | Indications and dose | Drug\",\"url\":\"https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose\",\"landing_url\":\"https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose\",\"topicType\":\"Drug\",\"boostvalue\":200,\"feedertype\":\"pfeeders\",\"sectionType\":\"indications-and-dose\",\"source_name\":\"BNF Monograph sections BNF\"},\"highlight\":{\"content\":[\"Indications and dose For paclitaxel Treatment of ovarian <mark>cancer</mark> (advanced or residual disease following laparotomy) in combination with cisplatin (conventional\",\"metastatic ovarian <mark>cancer</mark> where platinum-containing therapy has failed (conventional paclitaxel only),  Treatment of locally advanced breast <mark>cancer</mark> (in combination\",\"combination with other cytotoxics) or metastatic breast <mark>cancer</mark> (in combination with other cytotoxics or alone if other cytotoxics have failed or are inappropriate)\",\"breast <mark>cancer</mark> following treatment with anthracycline and cyclophosphamide (conventional paclitaxel only),  Treatment of non-small cell lung <mark>cancer</mark> (in combination\",\"failed (conventional paclitaxel only),  Monotherapy of metastatic breast <mark>cancer</mark> when first-line treatment has failed and standard, anthracycline-containing\"]}}]},\"aggregations\":{\"cardinality#unique_count\":{\"value\":555}}}\r\n"
   },
   "failed": false,
   "errorMessage": null,
   "parentResultUrl": null,
   "resultCount": 555,
   "rolledUpCount": 555,
   "unrolledCount": 555,
   "documents": [
     {
       "id": "2526117",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFTS"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2526117,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/treatment-summaries/breast-cancer/",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Treatment Summaries BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Description of condition Breast <mark>cancer</mark> is the most common form of malignancy in women, especially in those aged over 50 years....",
       "title": "Breast <b>cancer</b> | Treatment summary",
       "titleNoHtml": null,
       "boostValue": 150,
       "score": 92.83423,
       "titleParts": [
         "Breast <b>cancer</b> | Treatment summary"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/treatment-summaries/breast-cancer/",
       "debug": null
     },
     {
       "id": "2526287",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFTS"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2526287,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/treatment-summaries/prostate-cancer/",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Treatment Summaries BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Description of condition Prostate <mark>cancer</mark> is the most common form of <mark>cancer</mark> affecting men. It can also affect transgender...",
       "title": "Prostate <b>cancer</b> | Treatment summary",
       "titleNoHtml": null,
       "boostValue": 150,
       "score": 92.2832,
       "titleParts": [
         "Prostate <b>cancer</b> | Treatment summary"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/treatment-summaries/prostate-cancer/",
       "debug": null
     },
     {
       "id": "2521800",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2521800,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/pembrolizumab/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "lung <mark>cancer</mark>, Urothelial carcinoma, Classical Hodgkin lymphoma, Head and neck squamous cell carcinoma, Renal cell carcinoma, Colorectal...",
       "title": "Pembrolizumab | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 44.855076,
       "titleParts": [
         "Pembrolizumab | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/pembrolizumab/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2512665",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2512665,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/bevacizumab/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Colorectal <mark>cancer</mark> (specialist use only), Breast <mark>cancer</mark> (specialist use only), Renal cell carcinoma (specialist use only),...",
       "title": "Bevacizumab | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 44.110954,
       "titleParts": [
         "Bevacizumab | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/bevacizumab/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2516148",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2516148,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/epirubicin-hydrochloride/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "hydrochloride Breast <mark>cancer</mark> (specialist use only), Gastric <mark>cancer</mark> (specialist use only), Small cell lung...",
       "title": "Epirubicin hydrochloride | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 44.09298,
       "titleParts": [
         "Epirubicin hydrochloride | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/epirubicin-hydrochloride/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2515538",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2515538,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/docetaxel/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "node-negative breast <mark>cancer</mark> (in combination with doxorubicin and cyclophosphamide), Initial chemotherapy of locally advanced or...",
       "title": "Docetaxel | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 43.48902,
       "titleParts": [
         "Docetaxel | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/docetaxel/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2525112",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2525112,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/trastuzumab/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "breast <mark>cancer</mark> which overexpresses human epidermal growth factor receptor-2 (HER2) (initiated by a specialist), Treatment of metastatic...",
       "title": "Trastuzumab | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 43.454853,
       "titleParts": [
         "Trastuzumab | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/trastuzumab/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2520919",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2520919,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/niraparib/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Advanced ovarian <mark>cancer</mark> (initiated by a specialist), Advanced fallopian tube <mark>cancer</mark> (initiated by a specialist), Advanced...",
       "title": "Niraparib | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 43.159054,
       "titleParts": [
         "Niraparib | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/niraparib/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2517710",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2517710,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/goserelin/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Indications and dose Show For Zoladex LA ® Locally advanced prostate <mark>cancer</mark> as an alternative to surgical castration, Adjuvant treatment...",
       "title": "Goserelin | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 43.084724,
       "titleParts": [
         "Goserelin | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/goserelin/#indications-and-dose",
       "debug": null
     },
     {
       "id": "2521517",
       "tagsHigh": null,
       "guidanceRef": null,
       "xml": null,
       "abstract": null,
       "metaDescription": null,
       "accredited": false,
       "alternativePublicationDate": null,
       "altSourceNames": [
         "BNFBNF"
       ],
       "areaOfInterest": null,
       "breadcrumbs": null,
       "childDocumentCount": 0,
       "childDocuments": [
         
       ],
       "childDocumentsUrl": null,
       "clusterId": -2521517,
       "evidenceTypes": [
         
       ],
       "headings": null,
       "impact": null,
       "content": null,
       "contentId": "https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose",
       "index": 0,
       "lessSuitableForPrescribing": false,
       "niceDocType": [
         
       ],
       "niceGuidanceType": [
         
       ],
       "niceAdviceType": [
         
       ],
       "niceResultType": null,
       "parentPathTitle": null,
       "parentPathUrl": null,
       "parentPathWayUrl": null,
       "pathAndQuery": "/drugs/paclitaxel/#indications-and-dose",
       "primaryDrug": null,
       "publicationDate": null,
       "lastUpdated": null,
       "expectedPublicationDate": null,
       "consultationEndDate": null,
       "consultationType": null,
       "resourceType": [
         
       ],
       "guidanceStatus": [
         
       ],
       "publicationType": null,
       "publisher": null,
       "resourceCategory": null,
       "relatedLinks": null,
       "relatedLinkList": {
         
       },
       "technologyType": null,
       "topicSelectionDecision": null,
       "sourceName": "BNF Monograph sections BNF",
       "sourceUrl": "https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose",
       "staticAbstract": null,
       "subSectionLinks": null,
       "subSections": [
         
       ],
       "summaryUrl": null,
       "tags": [
         
       ],
       "teaser": "Indications and dose For paclitaxel Treatment of ovarian <mark>cancer</mark> (advanced or residual disease following laparotomy) in combination with...",
       "title": "Paclitaxel | Indications and dose | Drug",
       "titleNoHtml": null,
       "boostValue": 200,
       "score": 43.07801,
       "titleParts": [
         "Paclitaxel | Indications and dose | Drug"
       ],
       "ukmiSummaryUrl": null,
       "url": "https://beta-bnf.nice.org.uk/drugs/paclitaxel/#indications-and-dose",
       "debug": null
     }
   ],
   "pagerLinks": {
     "previous": null,
     "first": null,
     "pages": [
       {
         "title": "1",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=1&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 1,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": true
       },
       {
         "title": "2",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=2&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 2,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       },
       {
         "title": "3",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=3&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 3,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       },
       {
         "title": "4",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=4&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 4,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       },
       {
         "title": "5",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=5&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 5,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       },
       {
         "title": "6",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=6&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 6,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       },
       {
         "title": "7",
         "url": {
           "af": null,
           "am": null,
           "arms": null,
           "ci": null,
           "cid": null,
           "co": null,
           "em": null,
           "fc": null,
           "fd": null,
           "from": null,
           "fs": null,
           "fullUrl": "search?pa=7&q=cancer",
           "fullUrlWithDefaultRoot": "",
           "m": null,
           "om": null,
           "pa": 7,
           "pathTerm": null,
           "pbu": null,
           "ps": null,
           "pt": null,
           "pwbu": null,
           "q": "cancer",
           "rf": null,
           "s": null,
           "sa": null,
           "aggsOnly": null,
           "sm": null,
           "sn": null,
           "sp": null,
           "spuid": null,
           "sr": null,
           "ss": null,
           "syn": null,
           "t": null,
           "td": null,
           "title": null,
           "to": null,
           "route": "search"
         },
         "isCurrent": false
       }
     ],
     "next": {
       "af": null,
       "am": null,
       "arms": null,
       "ci": null,
       "cid": null,
       "co": null,
       "em": null,
       "fc": null,
       "fd": null,
       "from": null,
       "fs": null,
       "fullUrl": "search?pa=2&q=cancer",
       "fullUrlWithDefaultRoot": "",
       "m": null,
       "om": null,
       "pa": 2,
       "pathTerm": null,
       "pbu": null,
       "ps": null,
       "pt": null,
       "pwbu": null,
       "q": "cancer",
       "rf": null,
       "s": null,
       "sa": null,
       "aggsOnly": null,
       "sm": null,
       "sn": null,
       "sp": null,
       "spuid": null,
       "sr": null,
       "ss": null,
       "syn": null,
       "t": null,
       "td": null,
       "title": null,
       "to": null,
       "route": "search"
     }
   },
   "pageSize": 10,
   "firstResult": 1,
   "lastResult": 10,
   "finalSearchText": "cancer",
   "finalSearchTextNoStopWords": "cancer",
   "originalSearch": null,
   "navigators": [
     
   ],
   "unfilteredResultsUrl": null
 }